XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Common shares [Member]
Additional paid-in capital [Member]
Accumulated deficit [Member]
Total
Beginning Balance at Dec. 31, 2023 $ 18,761,250 $ 98,585 $ (17,748,387) $ 1,111,448
Beginning Balance (Shares) at Dec. 31, 2023 8,076,673      
Stock-based compensation $ 0 35,953 0 35,953
Net loss and comprehensive loss for the period 0 0 (1,707,358) (1,707,358)
Ending Balance at Mar. 31, 2024 $ 18,761,250 134,538 (19,455,745) (559,957)
Ending Balance (Shares) at Mar. 31, 2024 8,076,673      
Beginning Balance at Dec. 31, 2024 $ 30,518,195 1,520,412 (28,903,903) $ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024 11,816,721     11,816,721
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs $ 2,076,507 1,612,474 0 $ 3,688,981
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs (Shares) 1,490,000      
Issuance of common shares in connection with SEPA offering costs $ 300,000 0 0 300,000
Issuance of common shares in connection with SEPA offering costs (Shares) 105,840      
Issuance of common shares upon exercise of stock warrants $ 14,000 0 0 14,000
Issuance of common shares upon exercise of stock warrants (Shares) 5,000      
Stock-based compensation $ 0 112,277 0 112,277
Net loss and comprehensive loss for the period 0 0 (5,102,408) (5,102,408)
Ending Balance at Mar. 31, 2025 $ 32,908,702 $ 3,245,163 $ (34,006,311) $ 2,147,554
Ending Balance (Shares) at Mar. 31, 2025 13,417,561     13,417,561